Safety and efficacy of intrarenal arterial autologous CD34+ cell transfusion in patients with chronic kidney disease: A randomized, open‐label, controlled phase II clinical trial

Abstract Background This was a randomized, open‐label, controlled phase II clinical trial to investigate the safety, efficacy, and outcomes of intrarenal artery infusion of autologous peripheral‐blood‐derived CD34+ cells for patients with chronic kidney disease (CKD; ie, stage III or IV). Materials...

Полное описание

Библиографические подробности

Главные авторы:	Chih‐Chao Yang, Pei‐Hsun Sung, Ben‐Chung Cheng, Yi‐Chen Li, Yi‐Ling Chen, Mel S. Lee, Hon‐Kan Yip
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Oxford University Press 2020-08-01
Серии:	Stem Cells Translational Medicine
Предметы:	angiogenesis CD34+ cell therapy chronic kidney disease circulating endothelial progenitor cells
Online-ссылка:	https://doi.org/10.1002/sctm.19-0409
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!